Group IIA Secretory Phospholipase A 2 , Vascular Inflammation, and Incident Cardiovascular Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Group IIA Secretory Phospholipase A
2
, Vascular Inflammation, and Incident Cardiovascular Disease
Authors
Keywords
-
Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 39, Issue 6, Pages 1182-1190
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-04-11
DOI
10.1161/atvbaha.118.311894
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
- (2018) Paul M Ridker et al. LANCET
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease
- (2016) Fabrizio Giordanetto et al. ACS Medicinal Chemistry Letters
- Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease
- (2014) Nhat D. Quach et al. BIOCHEMICAL PHARMACOLOGY
- Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome
- (2014) Michelle L. O’Donoghue et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome
- (2014) Stephen J. Nicholls et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Proteolysis of Apolipoprotein A-I by Secretory Phospholipase A2
- (2014) Giorgio Cavigiolio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Expression of Type IIA Secretory Phospholipase A 2 Inhibits Cholesteryl Ester Transfer Protein Activity in Transgenic Mice
- (2013) Eva Hurt-Camejo et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Group X Secreted Phospholipase A2 Limits the Development of Atherosclerosis in LDL Receptor–Null Mice
- (2013) Hafid Ait-Oufella et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy
- (2013) Samia Mora et al. CIRCULATION
- Secretory Phospholipase A 2 -IIA and Cardiovascular Disease
- (2013) Michael V. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Phospholipase A 2 Enzymes, High-Dose Atorvastatin, and Prediction of Ischemic Events After Acute Coronary Syndromes
- (2012) Sung Kee Ryu et al. CIRCULATION
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- Phospholipase A2 enzymes and the risk of atherosclerosis
- (2012) R. S. Rosenson et al. EUROPEAN HEART JOURNAL
- On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy
- (2012) Samia Mora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
- (2011) Edward A. Dennis et al. CHEMICAL REVIEWS
- GCTA: A Tool for Genome-wide Complex Trait Analysis
- (2010) Jian Yang et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Lipoprotein-Associated and Secreted Phospholipases A 2 in Cardiovascular Disease
- (2010) Ziad Mallat et al. CIRCULATION
- Lipoprotein modification by secretory phospholipase A2 enzymes contributes to the initiation and progression of atherosclerosis
- (2009) Katariina Öörni et al. CURRENT OPINION IN LIPIDOLOGY
- Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease
- (2009) W. Koenig et al. EUROPEAN HEART JOURNAL
- Secretory phospholipase A2: A multifaceted family of proatherogenic enzymes
- (2009) Robert S. Rosenson et al. Current Cardiology Reports
- Secreted phospholipase A2 type IIA as a mediator connecting innate and adaptive immunity: new role in atherosclerosis
- (2008) E. Ibeas et al. CARDIOVASCULAR RESEARCH
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now